One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.

Elon Musk's brain implant startup, Neuralink, has raised $600 million in a funding round that values the company at $9 billion pre-money, Semafor ...

The birth took place at Sher-e-Kashmir University of Agricultural Sciences and Technology (SKUAST-Kashmir). Officials say it ...

The University of Virginia Medical Center is not just one of Newsweek’s top 50 hospitals in the country (and No. 1 in the ...

If he’d pursued his first love, Simon Cherry might be unraveling the mysteries of the universe through astronomy instead of ...

A remarkable aspect of this technology is its ability to project entirely different images depending on both the wavelength (color) and spin (polarization direction) of light. For example, ...

Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical ...

Researchers at SKUAST have achieved India's first gene-edited sheep using CRISPR-Cas9 technology. This breakthrough in animal ...

Lawmakers in Iowa, Idaho, Texas, and Kentucky have introduced bills that would ban or restrict vaccines that use messenger ...

Three-quarters of US-based researchers and graduate students are considering working abroad, according to a recent study.

Moving beyond traditional methods of observing thinly sliced and stained cancer tissues, a collaborative international ...

Tadaaki Taniguchi, M.D., Ph.D., Chief Research & Development Officer, Astellas | Astellas’ Chief R&D Officer, Tadaaki ...